| Dr Martha M Stagaman, MD | |
|
300 Main St, Lewiston, ME 04240-7027 | |
| (207) 795-7575 | |
| (207) 795-7133 |
| Full Name | Dr Martha M Stagaman |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 27 Years |
| Location | 300 Main St, Lewiston, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033184072 | NPI | - | NPPES |
| 200377740 | Medicaid | IN | |
| 2181017 | Medicaid | OH | |
| 64080427 | Medicaid | KY | |
| 110230632 | Other | OH | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 35-075318 (Ohio) | Primary |
| 208M00000X | Hospitalist | 35-075318 (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Maine Medical Center | Lewiston, ME | Hospital |
| Bridgton Hospital | Bridgton, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Maine Medical Center | 2567379563 | 347 |
| Bridgton Hospital | 8123919099 | 25 |
News Archive
Using night-vision goggle technology, near-infrared light, and high-resolution detectors, a wearable imaging device for awake infants with brain disorders was developed by a team of scientists and a pediatric neurosurgeon at The University of Texas Health Science Center at Houston (UTHealth).
Call them oil droplets with a brain or even "chemo-rats." Scientists in Illinois have developed a way to make simple oil droplets "smart" enough to navigate through a complex maze almost like a trained lab rat. The finding could have a wide range of practical implications, including helping cancer drugs to reach their target and controlling the movement of futuristic nano-machines, the scientists say.
The Boston Globe: "Massachusetts municipalities that offer employees, retirees, and elected officials the most generous and costly health insurance plans will feel the squeeze of the new national health care law's tax on 'Cadillac' insurance plans. A family health plan that costs more than $27,500 would be subject to a 40 percent tax on every dollar spent above that threshold.
Loyola University Medical Center is the first center in the country to enroll patients in a clinical trial of a minimally invasive treatment for patients living with cancer that has spread to the spine.
Although metastatic castration-resistant prostate cancer typically has limited response to immunotherapy, a subset of patients with pretreatment evidence of active T-cell responses in their tumors experienced prolonged survival following treatment with ipilimumab in a Phase II trial at The University of Texas MD Anderson Cancer Center.
› Verified 5 days ago
| Entity Name | Bridgton Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154370153 PECOS PAC ID: 8123919099 Enrollment ID: O20040322000534 |
News Archive
Using night-vision goggle technology, near-infrared light, and high-resolution detectors, a wearable imaging device for awake infants with brain disorders was developed by a team of scientists and a pediatric neurosurgeon at The University of Texas Health Science Center at Houston (UTHealth).
Call them oil droplets with a brain or even "chemo-rats." Scientists in Illinois have developed a way to make simple oil droplets "smart" enough to navigate through a complex maze almost like a trained lab rat. The finding could have a wide range of practical implications, including helping cancer drugs to reach their target and controlling the movement of futuristic nano-machines, the scientists say.
The Boston Globe: "Massachusetts municipalities that offer employees, retirees, and elected officials the most generous and costly health insurance plans will feel the squeeze of the new national health care law's tax on 'Cadillac' insurance plans. A family health plan that costs more than $27,500 would be subject to a 40 percent tax on every dollar spent above that threshold.
Loyola University Medical Center is the first center in the country to enroll patients in a clinical trial of a minimally invasive treatment for patients living with cancer that has spread to the spine.
Although metastatic castration-resistant prostate cancer typically has limited response to immunotherapy, a subset of patients with pretreatment evidence of active T-cell responses in their tumors experienced prolonged survival following treatment with ipilimumab in a Phase II trial at The University of Texas MD Anderson Cancer Center.
› Verified 5 days ago
| Entity Name | Central Maine Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689653487 PECOS PAC ID: 2567379563 Enrollment ID: O20040324000441 |
News Archive
Using night-vision goggle technology, near-infrared light, and high-resolution detectors, a wearable imaging device for awake infants with brain disorders was developed by a team of scientists and a pediatric neurosurgeon at The University of Texas Health Science Center at Houston (UTHealth).
Call them oil droplets with a brain or even "chemo-rats." Scientists in Illinois have developed a way to make simple oil droplets "smart" enough to navigate through a complex maze almost like a trained lab rat. The finding could have a wide range of practical implications, including helping cancer drugs to reach their target and controlling the movement of futuristic nano-machines, the scientists say.
The Boston Globe: "Massachusetts municipalities that offer employees, retirees, and elected officials the most generous and costly health insurance plans will feel the squeeze of the new national health care law's tax on 'Cadillac' insurance plans. A family health plan that costs more than $27,500 would be subject to a 40 percent tax on every dollar spent above that threshold.
Loyola University Medical Center is the first center in the country to enroll patients in a clinical trial of a minimally invasive treatment for patients living with cancer that has spread to the spine.
Although metastatic castration-resistant prostate cancer typically has limited response to immunotherapy, a subset of patients with pretreatment evidence of active T-cell responses in their tumors experienced prolonged survival following treatment with ipilimumab in a Phase II trial at The University of Texas MD Anderson Cancer Center.
› Verified 5 days ago
| Entity Name | Rumford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205991122 PECOS PAC ID: 3870583511 Enrollment ID: O20040514000890 |
News Archive
Using night-vision goggle technology, near-infrared light, and high-resolution detectors, a wearable imaging device for awake infants with brain disorders was developed by a team of scientists and a pediatric neurosurgeon at The University of Texas Health Science Center at Houston (UTHealth).
Call them oil droplets with a brain or even "chemo-rats." Scientists in Illinois have developed a way to make simple oil droplets "smart" enough to navigate through a complex maze almost like a trained lab rat. The finding could have a wide range of practical implications, including helping cancer drugs to reach their target and controlling the movement of futuristic nano-machines, the scientists say.
The Boston Globe: "Massachusetts municipalities that offer employees, retirees, and elected officials the most generous and costly health insurance plans will feel the squeeze of the new national health care law's tax on 'Cadillac' insurance plans. A family health plan that costs more than $27,500 would be subject to a 40 percent tax on every dollar spent above that threshold.
Loyola University Medical Center is the first center in the country to enroll patients in a clinical trial of a minimally invasive treatment for patients living with cancer that has spread to the spine.
Although metastatic castration-resistant prostate cancer typically has limited response to immunotherapy, a subset of patients with pretreatment evidence of active T-cell responses in their tumors experienced prolonged survival following treatment with ipilimumab in a Phase II trial at The University of Texas MD Anderson Cancer Center.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Martha M Stagaman, MD 300 Main St, Lewiston, ME 04240-7027 Ph: (207) 795-7575 | Dr Martha M Stagaman, MD 300 Main St, Lewiston, ME 04240-7027 Ph: (207) 795-7575 |
News Archive
Using night-vision goggle technology, near-infrared light, and high-resolution detectors, a wearable imaging device for awake infants with brain disorders was developed by a team of scientists and a pediatric neurosurgeon at The University of Texas Health Science Center at Houston (UTHealth).
Call them oil droplets with a brain or even "chemo-rats." Scientists in Illinois have developed a way to make simple oil droplets "smart" enough to navigate through a complex maze almost like a trained lab rat. The finding could have a wide range of practical implications, including helping cancer drugs to reach their target and controlling the movement of futuristic nano-machines, the scientists say.
The Boston Globe: "Massachusetts municipalities that offer employees, retirees, and elected officials the most generous and costly health insurance plans will feel the squeeze of the new national health care law's tax on 'Cadillac' insurance plans. A family health plan that costs more than $27,500 would be subject to a 40 percent tax on every dollar spent above that threshold.
Loyola University Medical Center is the first center in the country to enroll patients in a clinical trial of a minimally invasive treatment for patients living with cancer that has spread to the spine.
Although metastatic castration-resistant prostate cancer typically has limited response to immunotherapy, a subset of patients with pretreatment evidence of active T-cell responses in their tumors experienced prolonged survival following treatment with ipilimumab in a Phase II trial at The University of Texas MD Anderson Cancer Center.
› Verified 5 days ago
Sandra L Harris, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 99 Campus Ave, Suite 301, Lewiston, ME 04240 Phone: 207-777-4320 Fax: 207-777-4331 | |
Lauren M Desmarais, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 99 Campus Ave, Suite 201, Lewiston, ME 04240 Phone: 207-777-8810 Fax: 207-777-8155 | |
Dr. Jessica Ana Kvasic, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 99 Campus Ave Ste 301, Lewiston, ME 04240 Phone: 077-775-3002 | |
Dr. Winoah Anya Henry, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 77 Bates St Ste 202, Lewiston, ME 04240 Phone: 207-784-5784 | |
Dr. John D Dickens Jr., MD, MPH, SFHM Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Main St, Lewiston, ME 04240 Phone: 207-795-0111 | |
Nicholette Erickson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12 High St Ste 6, Lewiston, ME 04240 Phone: 207-795-2935 |